Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ivabradine and autonomic blockade in athlete bradycardia
ACTRN12617000983303Phase 4Recruiting
- Sponsor
- Baker Heart and Diabetes Institute
- Start
- Jul 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of ivabradine in bradyarrhythmia (2 arms), sponsored by Baker Heart and Diabetes Institute. Primary endpoints: Resting heart rate on ECG and Peak heart rate on ECG monitoring. Started Jul 2017; status: recruiting.
02
Drugs
ivabradine
03
Conditions
bradyarrhythmia
Beyond the preview
Go deeper on ACTRN12617000983303.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12617000983303.